(FILES) This photograph taken on October 14, 2024 shows Doliprane, the brand under which healthcare giant Sanofi sells paracetamol, a non-opioid analgesic to ease mild to moderate pain, and of fever, at the Doliprane medication production site of French multinational pharmaceutical and healthcare company Sanofi, in Lisieux, northern France. Pharmaceutical group Sanofi confirmed on ocotber 21, 2024 that it had signed an alliance with US investment fund CD&R to potentially sell control of its subsidiary Opella, which markets Doliprane. (Photo by Lou BENOIST / AFP) (Photo by LOU BENOIST/AFP via Getty Images)